Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
L Elkrief, V Hernandez-Gea, M Senzolo… - The lancet …, 2024 - thelancet.com
Portal vein thrombosis (PVT) refers to the development of a non-malignant obstruction of the
portal vein, its branches, its radicles, or a combination. This Review first provides a …
portal vein, its branches, its radicles, or a combination. This Review first provides a …
EASL position paper on clinical follow-up after HCV cure
T Reiberger, S Lens, G Cabibbo, P Nahon… - Journal of …, 2024 - Elsevier
Following the advent of direct-acting antivirals (DAAs), hepatitis C virus (HCV) infection can
be cured in almost all infected patients. This has led to a number of clinical questions …
be cured in almost all infected patients. This has led to a number of clinical questions …
AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis
This Practice Guidance from the American Association for the Study of Liver Disease
(AASLD) intends to coalesce best practice recommendations for the identification of portal …
(AASLD) intends to coalesce best practice recommendations for the identification of portal …
[HTML][HTML] Dynamics in liver stiffness measurements predict outcomes in advanced chronic liver disease
Background & Aims Liver stiffness measurements (LSMs) provide an opportunity to monitor
liver disease progression and regression noninvasively. We aimed to determine the …
liver disease progression and regression noninvasively. We aimed to determine the …
AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension
Abbreviations: ALD, alcohol-associated liver disease; APRI, aspartate aminotransferase–
platelet ratio index; ARFI, acoustic radiation force impulse; AUROC, area under the receiver …
platelet ratio index; ARFI, acoustic radiation force impulse; AUROC, area under the receiver …
[HTML][HTML] Noninvasive assessment of hepatic decompensation
Noninvasive tests (NITs) are used in all aspects of liver disease management. Their most
prominent break-through since the millennium has been in advancing early detection of liver …
prominent break-through since the millennium has been in advancing early detection of liver …
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
M Mandorfer, E Aigner, M Cejna, A Ferlitsch… - Wiener klinische …, 2023 - Springer
The Billroth IV consensus was developed during a consensus meeting of the Austrian
Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of …
Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of …
Beta-blockers in the era of precision medicine in patients with cirrhosis
A Albillos, A Krag - Journal of Hepatology, 2023 - Elsevier
For decades, non-selective beta-blockers (NSBBs) have been the standard of care for the
primary and secondary prevention of bleeding from oesophageal varices. However, several …
primary and secondary prevention of bleeding from oesophageal varices. However, several …
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis
J Berenguer, T Aldámiz-Echevarría, V Hontañón… - Hepatology, 2025 - journals.lww.com
Conclusions: Non-liver non-AIDS–related events were the leading causes of morbidity and
mortality after direct-acting antiviral cure among coinfected patients with advanced …
mortality after direct-acting antiviral cure among coinfected patients with advanced …
[HTML][HTML] Non-invasive tools for compensated advanced chronic liver disease and portal hypertension after Baveno VII–an update
Non-invasive tests (NITs) and liver stiffness measurement (LSM) in particular, have entered
clinical practice over 20 years ago as point-of-care tests to diagnose liver fibrosis in patients …
clinical practice over 20 years ago as point-of-care tests to diagnose liver fibrosis in patients …